RecruitingNCT06515964

China Early Esophageal Cancer Cohort

Studying Carcinoma of esophagus

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Changhai Hospital
Intervention
observational study(other)
Enrollment
1000 enrolled
Eligibility
15-85 years · All sexes
Timeline
2022 – 2025

Study locations (1)

Collaborators

Lianshui People's Hospital · The second affiliated hospital of Xuzhou medical university · The second people's hospital of Nanyang · Nanchong Central Hospital · Tongliao City Hospital · Yancheng First People's Hospital · The Second Hospital of Hebei Medical University · The Second Affiliated Hospital of Baotou Medical College · Affiliated Hospital of Southwest Medical University · Sichuan Cancer Hospital and Research Institute · The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School · Zhongda Hospital · The First Affiliated Hospital with Nanjing Medical University · West China Hospital · The First Affiliated Hospital of Soochow University · Jiangsu Province Hospital of Traditional Chinese Medicine · Shandong Provincial Hospital · Shanxi Provincial People's Hospital · Henan Provincial People's Hospital · Anyang Cancer Hospital

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06515964 on ClinicalTrials.gov

Other trials for Carcinoma of esophagus

Additional recruiting or active studies for the same condition.

See all trials for Carcinoma of esophagus →

← Back to all trials